Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
| Status: | Archived |
|---|---|
| Conditions: | Blood Cancer, Infectious Disease, HIV / AIDS, Lymphoma, Hematology, Leukemia |
| Therapuetic Areas: | Hematology, Immunology / Infectious Diseases, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2002 |
| End Date: | December 2012 |
Unrelated Donor Stem Cell Transplant for Patients With Malignant and Non-Malignant Disorders
Unrelated matched donor (cord blood, bone marrow or peripheral blood) allogeneic stem cell
transplantation (UDAlloSCT) with either myeloablative or reduced intensity conditioning will
be well tolerated and result in a high degree of engraftment in patients with selected
malignant and non malignant disorders.
This is a non-randomized study to determine the tolerability and degree of engraftment of
unrelated matched donor allogeneic stem cell transplantation with either myeloablative or
reduced intensity conditioning in patients with selected malignant and non malignant
disorders. Patients will receive one of either full intensity or reduced intensity regimen
based on the patient's disease status, organ function and performance and determined by the
PI.
We found this trial at
1
site
Columbia Presbyterian Med Ctr On January 1, 1998, The New York Hospital publicly announced its...
Click here to add this to my saved trials
